<!– –> <!– Page Last Updated: 11/02/2011 –> Page Last Updated: 11/02/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Public Workshop
The Food and Drug Administration (FDA) is announcing a public workshop entitled: “Using Scientific Research Data to Support Pediatric Medical Device Claims: A Public Dialogue.†The purpose of the public workshop is to receive public comment on the use of scientific research data, including published scientific literature, to extrapolate effectiveness claims from adults to children…
FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
This update is in follow-up to the FDA Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder (ADHD) Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare ProfessionalsData Summary  Safety Announcement [11-01-2011] The U.S. Food and Drug Administration (FDA) is updating the public that a large, recently-completed study in…